These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14727849)

  • 1. Effect of several factors on the mechanical properties of pressure-sensitive adhesives used in transdermal therapeutic systems.
    Dimas DA; Dallas PP; Rekkas DD; Choulis NH
    AAPS PharmSciTech; 2000 Jun; 1(2):E16. PubMed ID: 14727849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and in vitro evaluation of new drug-in-adhesive formulations of fentanyl transdermal patches.
    Mehdizadeh A; Toliate T; Rouini MR; Abashzadeh S; Dorkoosh F
    Acta Pharm; 2004 Dec; 54(4):301-17. PubMed ID: 15634614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pressure sensitive adhesives and chemical permeation enhancers on the permeability of fentanyl through excised rat skin.
    Mehdizadeh A; Ghahremani MH; Rouini MR; Toliyat T
    Acta Pharm; 2006 Jun; 56(2):219-29. PubMed ID: 16613727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of formulated tenoxicam transdermal delivery systems.
    Kim T; Kang E; Chun I; Gwak H
    J Pharm Pharmacol; 2008 Jan; 60(1):135-8. PubMed ID: 18088513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of carboxyl group of pressure sensitive adhesive in controlled release of propranolol in transdermal patch: Quantitative determination of ionic interaction and molecular mechanism characterization.
    Yang D; Wan X; Quan P; Liu C; Fang L
    Eur J Pharm Sci; 2018 Mar; 115():330-338. PubMed ID: 29414309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design.
    Roy SD; Gutierrez M; Flynn GL; Cleary GW
    J Pharm Sci; 1996 May; 85(5):491-5. PubMed ID: 8742940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current pharmaceutical design on adhesive based transdermal drug delivery systems.
    Ghosh A; Banerjee S; Kaity S; Wong TW
    Curr Pharm Des; 2015; 21(20):2771-83. PubMed ID: 25925119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adhesive properties: a critical issue in transdermal patch development.
    Cilurzo F; Gennari CG; Minghetti P
    Expert Opin Drug Deliv; 2012 Jan; 9(1):33-45. PubMed ID: 22171789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug in adhesive patch of palonosetron: Effect of pressure sensitive adhesive on drug skin permeation and in vitro-in vivo correlation.
    Liu C; Hui M; Quan P; Fang L
    Int J Pharm; 2016 Sep; 511(2):1088-97. PubMed ID: 27521703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systemic evaluation of drug in acrylic pressure sensitive adhesive patch in vitro and in vivo: The roles of intermolecular interaction and adhesive mobility variation in drug controlled release.
    Liu C; Quan P; Li S; Zhao Y; Fang L
    J Control Release; 2017 Apr; 252():83-94. PubMed ID: 28274741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of permeation enhancers on dynamic mechanical properties of acrylate pressure sensitive adhesives.
    Khire A; Vavia P
    Int J Pharm; 2013 Dec; 458(1):141-7. PubMed ID: 24120455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug release and adhesive properties of crospovidone-containing matrix patches based on polyisobutene and acrylic adhesives.
    Schulz M; Fussnegger B; Bodmeier R
    Eur J Pharm Sci; 2010 Dec; 41(5):675-84. PubMed ID: 20883778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal nitroglycerin delivery using acrylic matrices: design, formulation, and in vitro characterization.
    Savoji H; Mehdizadeh A; Ramazani Saadat Abadi A
    ISRN Pharm; 2014; 2014():493245. PubMed ID: 24511396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of transdermal therapeutic formulation of CNS5161, a novel NMDA receptor antagonist, by utilizing pressure-sensitive adhesives II: improved transdermal absorption and evaluation of efficacy and safety.
    Naruse M; Ogawara K; Kimura T; Konishi R; Higaki K
    Eur J Pharm Sci; 2014 Feb; 52():86-94. PubMed ID: 24215737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of transdermal therapeutic formulation of CNS5161, a novel N-methyl-D-aspartate receptor antagonist, by utilizing pressure-sensitive adhesives I.
    Naruse M; Ogawara K; Kimura T; Konishi R; Higaki K
    Biol Pharm Bull; 2012; 35(3):321-8. PubMed ID: 22382317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in transdermal drug delivery.
    Subedi RK; Oh SY; Chun MK; Choi HK
    Arch Pharm Res; 2010 Mar; 33(3):339-51. PubMed ID: 20361297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Water-compatible cross-linked pyrrolidone acrylate pressure-sensitive adhesives with persistent adhesion for transdermal delivery: Synergistic effect of hydrogen bonding and electrostatic force.
    Gong K; Sun P; Cai Y; Wang X; Pang Y; Liu C; Guo J; Fang L
    Acta Biomater; 2024 Apr; 179():130-148. PubMed ID: 38460932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation optimization and stability study of transdermal therapeutic system of nicorandil.
    Tipre DN; Vavia PR
    Pharm Dev Technol; 2002; 7(3):325-32. PubMed ID: 12229264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confocal Raman investigation of diffusion processes in monolithic type transdermal drug delivery systems.
    Meyer S; Heinsohn G; Wolber R; Pörtner R; Nierle J
    Drug Deliv; 2015 Dec; 22(8):1103-1110. PubMed ID: 24580682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigations on the viscoelastic performance of pressure sensitive adhesives in drug-in-adhesive type transdermal films.
    Wolff HM; Irsan ; Dodou K
    Pharm Res; 2014 Aug; 31(8):2186-202. PubMed ID: 24599801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.